Type of hormone therapy and risk of misclassification at mammography screening

Sisse Helle Njor, Jesper Hallas, Walter Schwartz, Elsebeth Lynge, Anette Tønnes Pedersen

    9 Citationer (Scopus)

    Abstract

    Current users of hormone therapy (HT) are known to have a lower accuracy of mammography screening than do never users. We studied whether the risk of misclassification depends on type of hormone, administration, regimen, and dose of the therapy.
    OriginalsprogEngelsk
    TidsskriftMenopause (New York, N.Y.)
    Vol/bind18
    Udgave nummer2
    Sider (fra-til)171-7
    Antal sider7
    DOI
    StatusUdgivet - 1 feb. 2011

    Fingeraftryk

    Dyk ned i forskningsemnerne om 'Type of hormone therapy and risk of misclassification at mammography screening'. Sammen danner de et unikt fingeraftryk.

    Citationsformater